Prognostic role of epidermal growth factor receptor in nasopharyngeal carcinoma: A meta‐analysis
Authors:
- 30 August 2013
- journal article
- review article
- Published by Wiley in Head & Neck
- Vol. 36 (10) , 1508-1516
Abstract
Background: Various studies have assessed the prognostic value of epidermal growth factor receptor (EGFR) overexpression in nasopharyngeal carcinoma (NPC), but their results remain controversial.Methods: Studies published up to January 2013 were collected. A total of 16 studies involving 1179 patients were reviewed. A meta‐analysis was performed to clarify the prognostic role of EGFR in patients with NPC. The combined hazard ratio (HR) and 95% confidence interval (CI) were estimated using fixed‐effects or random‐effects models.Results: EGFR overexpression had significantly poor effect on overall survival (OS; HR, 1.86; 95% CI, 1.25–2.77), disease‐free survival (DFS; HR, 2.25; 95% CI, 1.66–3.04) and locoregional control (HR, 2.93; 95% CI, 1.71–5.02). However, the association between EGFR overexpression and distant metastasis–free survival was not statistically significant (HR, 1.39; 95% CI, 0.72–2.67).Conclusion: EGFR overexpression can be a prognostic factor for patients with NPC. © 2013 Wiley Periodicals, Inc. Head Neck, 36: 1508–1516, 2014Keywords
This publication has 44 references indexed in Scilit:
- Prognostic value and differences of the sixth and seventh editions of the UICC/AJCC staging systems in nasopharyngeal carcinomaJournal of Cancer Research and Clinical Oncology, 2012
- Long‐term survival analysis of nasopharyngeal carcinoma by plasma Epstein‐Barr virus DNA levelsCancer, 2012
- Current Management of Nasopharyngeal CancerSeminars in Radiation Oncology, 2012
- Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysisThe Lancet Oncology, 2012
- Eight-Signature Classifier for Prediction of Nasopharyngeal Carcinoma SurvivalJournal of Clinical Oncology, 2011
- Targeting the human EGFR family in esophagogastric cancerNature Reviews Clinical Oncology, 2011
- EGFR pathway in advanced non-small cell lung cancerFrontiers in Bioscience-Scholar, 2011
- Serologic Antienzyme Rate of Epstein-Barr Virus DNase-Specific Neutralizing Antibody Segregates TNM Classification in Nasopharyngeal CarcinomaJournal of Clinical Oncology, 2010
- Epidermal growth factor receptor as a prognostic factor in locally advanced rectal-cancer patients treated with preoperative chemoradiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Quantification of Plasma Epstein–Barr Virus DNA in Patients with Advanced Nasopharyngeal CarcinomaNew England Journal of Medicine, 2004